9 November 2026
EMV Capital plc
(EMV Capital or EMVC or the Company or the Group)
CHANGE OF NOMINATED ADVISER AND CHANGE OF BROKER
EMV Capital Plc (AIM: EMVC), the deep tech and life sciences VC investment group, is pleased to announce the appointment of Grant Thornton UK Advisory & Tax LLP as its Nominated Adviser and Shore Capital Stockbrokers Limited as its Broker, with immediate effect.
-ends-
For more information, please contact:
|
|
|
|
EMV Capital plc |
via Rosewood |
|
Ilian Iliev, CEO |
|
|
|
|
|
Grant Thornton UK Advisory & Tax LLP (Nominated Adviser) |
+44 (0)20 7383 5100 |
|
Jamie Barklem / Harrison Clarke / Ciara Donnelly / Elliot Peters |
|
|
|
|
|
Shore Capital (Broker) |
+44 (0)20 7408 4090 |
|
Mark Percy / Fiona Conroy |
|
|
|
|
|
Rosewood (Financial PR) |
+44 (0)20 7653 8702 |
|
John West / Llewellyn Angus / Lily Sutton |
|
About EMV Capital plc (EMVC)
EMV Capital plc, is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies. With a focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, EMV Capital invests in, manages and strengthens early-stage IP-rich companies.
EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. EMV Capital's investment thesis is realised through these capital sources:
capital-efficient investments through Group balance sheet;
fund management of the Evergreen EIS and Martlet Capital Funds;
syndicated investments leveraging its network of third-party investors.
EMV Capital's approach is characterised by its proactive management style, aiming to advance portfolio companies to critical value inflection points by actively engaging with them. Companies are supported through Board representation and the use of its Value Creation Services practice.
Headquartered in London, with a Cambridge presence and strong international links, EMV Capital is quoted on AIM, a market operated by the London Stock Exchange.
Existing Board - AIM Rule 17 Disclosure
The Company confirms the following director disclosures pursuant to AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.
Dr Charles Spicer
Dr Charles Spicer was previously a non-executive director of MJ Hudson Group Plc, resigning on 19 December 2022. After he had left the board, the company entered into a Creditors’ Winding Up on 11 August 2023. The Company is currently still in liquidation.